Prioritization to foster equitable access to RSV preventive monoclonal antibodies and antivirals for children

TNM001 - Guangzhou Trinomab Biotechnology

ziresovir (AK0529) - Ark Biosci

Enflonsia (clesrovimab-cfor) - Merck (MSD)

Beyfortus (nirsevimab) - Sanofi

Tiziana Masini 1; Daniel Feikin 2; Yasir Bin Nisar 3; Erin Sparrow 2; Wilson Were 3; Martina Penazzato 1

Feb 10, 2026